montelukast 10 MG Oral Tablet
1 INDICATIONS AND USAGE Montelukast sodium is a leukotriene receptor antagonist indicated for: • Prophylaxis and chronic treatment of asthma in patients 12 months of age and older ( 1.1 ). • Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older ( 1.2 ). • Relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients 2 years of age and older, and perennial allergic rhinitis (PAR) in patients 6 months of age and older ( 1.3 ). 1.1 Asthma Montelukast sodium is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. 1.2 Exercise-Induced Bronchoconstriction (EIB) Montelukast sodium is indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older. 1.3 allergic rhinitis Montelukast sodium is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older.
Mylan Pharmaceuticals Inc.
ROUND BLUE ML 1
Related Pills
montelukast 5 MG Chewable Tablet
Mylan Pharmaceuticals Inc.
montelukast 4 MG Chewable Tablet
Mylan Pharmaceuticals Inc.
losartan potassium 100 mg
novadoz pharmaceuticals llc
losartan potassium 25 mg
Novadoz Pharmaceuticals LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Montelukast Sodium Tablets are available containing 10.4 mg montelukast sodium, USP which is equivalent to 10 mg of montelukast. The 10 mg tablets are blue, film-coated, round, unscored tablets debossed with ML over 1 on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-5201-93 bottles of 30 tablets Montelukast Sodium Chewable Tablets are available containing 4.2 mg and 5.2 mg montelukast sodium, USP which are equivalent to 4 mg and 5 mg of montelukast, respectively. The 4 mg chewable tablets are light pink, round, unscored tablets debossed with ML over 4 on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-5204-93 bottles of 30 tablets The 5 mg chewable tablets are dark pink, round, unscored tablets debossed with ML over 5 on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-5205-93 bottles of 30 tablets Montelukast Sodium Oral Granules are available containing 4.2 mg of montelukast sodium, USP equivalent to 4 mg of montelukast. Each carton contains 30 packets containing approximately 500 mg net weight of white to off-white powder in each packet. The packets are child-resistant, tearable foil. See packet and carton for product information. They are available as follows: NDC 0378-6040-93 1 carton (30 packets per carton) Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture and light. Store in original package. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. PHARMACIST: Dispense a Patient Information Leaflet with each prescription.
More pills like ROUND ML 1